Bayer CropScience Declines 4.82%: 3 Key Factors Driving the Weekly Downtrend

2 hours ago
share
Share Via
Bayer CropScience Ltd ended the week down 4.82% to close at Rs.4,492.10, underperforming the Sensex which declined 1.46% over the same period. The week was marked by a sharp initial drop, a brief recovery midweek, and a technical downgrade that culminated in a bearish momentum shift. Despite some short-term rallies, the stock faced persistent selling pressure amid valuation concerns and mixed technical signals.

Key Events This Week

Mar 23: Sharp 5.00% drop amid technical momentum shift

Mar 24: Partial recovery with 2.03% gain alongside Sensex rally

Mar 25: Technical downgrade to Sell rating announced

Mar 27: Bearish momentum confirmed with further decline

Week Open
Rs.4,719.35
Week Close
Rs.4,492.10
-4.82%
Week High
Rs.4,574.30
vs Sensex
-3.36%

Monday, 23 March 2026: Technical Momentum Shift Amid Market Weakness

Bayer CropScience opened the week on a weak note, closing at Rs.4,483.45, down 5.00% from the previous Friday’s close of Rs.4,719.35. This decline was sharper than the Sensex’s 3.13% drop to 32,377.87, signalling relative underperformance. The day’s price action reflected a notable shift in technical momentum from mildly bearish to bearish, as key indicators such as MACD and moving averages deteriorated. Despite an intraday rally pushing the stock to Rs.4,699.80, the closing price settled near the day’s low, indicating selling pressure. Volume was elevated at 1,782, suggesting active trading amid the technical shift.

Tuesday, 24 March 2026: Partial Recovery on Broader Market Rally

The stock rebounded 2.03% to close at Rs.4,574.30, supported by a strong Sensex gain of 1.95% to 33,009.57. This recovery was modest and accompanied by lower volume of 798, indicating cautious buying interest. Technical indicators showed mixed signals, with weekly MACD mildly bullish but monthly trends remaining bearish. The partial bounce suggested short-term relief but did not reverse the prevailing downtrend. The stock remained below key moving averages, limiting upside potential.

Fast mover alert! This Large Cap from Automobiles - Passeenger just qualified for our Momentum list with stellar technical indicators. Strike while the iron is hot!

  • - Recent Momentum qualifier
  • - Stellar technical indicators
  • - Large Cap fast mover

Strike Now - View Stock →

Wednesday, 25 March 2026: Downgrade to Sell Amid Valuation and Technical Concerns

The stock declined 1.57% to Rs.4,502.50, underperforming the Sensex’s 1.93% gain to 33,645.89. This day marked a significant development as MarketsMOJO downgraded Bayer CropScience from a Hold to a Sell rating, citing deteriorating technical indicators and expensive valuation metrics. The Mojo Score dropped to 44.0, reflecting increased caution. Despite strong quarterly earnings growth—Profit Before Tax excluding other income surged 6,835.71% to Rs.97.10 crores and PAT rose 179.8% to Rs.95.70 crores—the company’s long-term growth remained subdued, with net sales CAGR of 7.11% and operating profit growth of just 0.95% over five years. The stock’s Price to Book ratio of 6.5 and modest PEG ratio of 1.1 suggested valuation challenges amid mixed fundamentals.

Friday, 27 March 2026: Bearish Momentum Confirmed with Further Decline

After no trading data on 26 March, Bayer CropScience closed the week at Rs.4,492.10, down 0.23% from the previous close. The Sensex fell 2.11% to 32,935.19, but the stock’s weekly performance remained weaker overall. Technical momentum deteriorated further, with daily moving averages firmly bearish and Bollinger Bands indicating downside pressure. The MACD showed conflicting signals—weekly mildly bullish but monthly bearish—while the RSI hovered neutral. On-Balance Volume was mildly bearish, reflecting weak volume support for price gains. The stock traded near its 52-week low of Rs.4,276.85, underscoring the risk of further downside. The downgrade to Sell and technical deterioration suggest caution amid ongoing volatility.

Is Bayer CropScience Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!

  • - Better alternatives suggested
  • - Cross-sector comparison
  • - Portfolio optimization tool

Find Better Alternatives →

Daily Price Performance: Bayer CropScience vs Sensex

Date Stock Price Day Change Sensex Day Change
2026-03-23 Rs.4,483.45 -5.00% 32,377.87 -3.13%
2026-03-24 Rs.4,574.30 +2.03% 33,009.57 +1.95%
2026-03-25 Rs.4,502.50 -1.57% 33,645.89 +1.93%
2026-03-27 Rs.4,492.10 -0.23% 32,935.19 -2.11%

Key Takeaways

Positive Signals: Bayer CropScience demonstrated strong short-term earnings growth in Q3 FY25-26, with profit before tax excluding other income surging by over 6,800% and PAT rising nearly 180% year-on-year. The weekly MACD showed mild bullishness at times, indicating potential for short-term rallies. The stock’s valuation, while expensive on a Price to Book basis, trades at a discount relative to peers, offering some relative value within the sector.

Cautionary Signals: The stock underperformed the Sensex significantly over the week, falling 4.82% versus the benchmark’s 1.46% decline. Technical momentum shifted decisively to bearish, with daily moving averages and Bollinger Bands signalling downside risk. The downgrade from Hold to Sell by MarketsMOJO reflects concerns over expensive valuation, subdued long-term growth, and weakening technical indicators. Volume trends and On-Balance Volume remain bearish, suggesting limited conviction behind price advances. The stock’s proximity to its 52-week low highlights vulnerability to further declines.

Conclusion

Bayer CropScience Ltd’s week was characterised by a sharp initial decline, a brief midweek recovery, and a subsequent technical downgrade that confirmed bearish momentum. Despite impressive quarterly earnings growth, the stock’s long-term growth prospects remain modest, and valuation metrics suggest limited margin for error. The downgrade to a Sell rating and deteriorating technical indicators underscore the risks facing the stock in the near term. Investors should exercise caution and closely monitor price action, volume trends, and upcoming sector developments before considering exposure. The stock’s underperformance relative to the Sensex and persistent technical weakness suggest a challenging environment ahead.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News